209 related articles for article (PubMed ID: 36210658)
1. Invasive and Non-invasive Ductal Carcinoma within Malignant Phyllodes Tumour with Axillary Lymph Node Metastases.
Erdogan O; Parlakgumus A; Tas ZA; Yener K; Turan U
J Coll Physicians Surg Pak; 2022 Aug; 32(8):S92-S94. PubMed ID: 36210658
[TBL] [Abstract][Full Text] [Related]
2. Variations in the management of the axilla in screen-detected ductal carcinoma in situ: evidence from the UK NHS breast screening programme audit of screen detected DCIS.
Nicholson S; Hanby A; Clements K; Kearins O; Lawrence G; Dodwell D; Bishop H; Thompson A;
Eur J Surg Oncol; 2015 Jan; 41(1):86-93. PubMed ID: 25441934
[TBL] [Abstract][Full Text] [Related]
3. Predictors of invasion and axillary lymph node metastasis in patients with a core biopsy diagnosis of ductal carcinoma in situ: an analysis of 255 cases.
Han JS; Molberg KH; Sarode V
Breast J; 2011; 17(3):223-9. PubMed ID: 21545433
[TBL] [Abstract][Full Text] [Related]
4. Malignant phyllodes tumour with intraductal and invasive carcinoma and lymph node metastasis.
Korula A; Varghese J; Thomas M; Vyas F; Korula A
Singapore Med J; 2008 Nov; 49(11):e318-21. PubMed ID: 19037540
[TBL] [Abstract][Full Text] [Related]
5. Is Sentinel Lymph Node Biopsy Necessary for Ductal Carcinoma In Situ Patients Undergoing Mastectomy?
Miller-Ocuin JL; Howard-McNatt M; Levine EA; Chiba A
Am Surg; 2020 Aug; 86(8):955-957. PubMed ID: 32862671
[TBL] [Abstract][Full Text] [Related]
6. Can additional histopathological examination of ultrasound-guided axillary lymph node core biopsies improve preoperative diagnosis of primary breast cancer nodal metastasis?
Mullen R; Purdie CA; Jordan LB; McLean D; Whelehan P; Vinnicombe S; Brown DC; Evans A
Clin Radiol; 2013 Jul; 68(7):704-7. PubMed ID: 23518495
[TBL] [Abstract][Full Text] [Related]
7. The Influence of Hospital and Surgeon Factors on the Prevalence of Axillary Lymph Node Evaluation in Ductal Carcinoma In Situ.
Coromilas EJ; Wright JD; Huang Y; Feldman S; Neugut AI; Chen L; Hershman DL
JAMA Oncol; 2015 Jun; 1(3):323-32. PubMed ID: 26181180
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for lymph node metastases in breast ductal carcinoma in situ with minimal invasive component.
Wasserberg N; Morgenstern S; Schachter J; Fenig E; Lelcuk S; Gutman H
Arch Surg; 2002 Nov; 137(11):1249-52. PubMed ID: 12413311
[TBL] [Abstract][Full Text] [Related]
9. Invasive Ductal Carcinoma within a Benign Phyllodes Tumor.
Panko N; Jebran AA; Gomberawalla A; Connolly M
Am J Case Rep; 2017 Jul; 18():813-816. PubMed ID: 28724885
[TBL] [Abstract][Full Text] [Related]
10. Ductal carcinoma in situ: value of sentinel lymph node biopsy.
Sakr R; Barranger E; Antoine M; Prugnolle H; Daraï E; Uzan S
J Surg Oncol; 2006 Oct; 94(5):426-30. PubMed ID: 16967457
[TBL] [Abstract][Full Text] [Related]
11. Is Axillary Assessment of Ductal Carcinoma In Situ of the Breast Necessary in All Cases?
Bellver G; Buch E; Ripoll F; Adrianzen M; Bermejo B; Burgues O; Julve A; Ortega J
J Surg Res; 2022 Mar; 271():145-153. PubMed ID: 34902737
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of sentinel lymph node biopsy in detection of axillary lymph node metastasis in breast cancer].
Zhang JG; Zhong L; Li CL
Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):235-6. PubMed ID: 17649646
[No Abstract] [Full Text] [Related]
13. Trends and clinicopathological predictors of axillary evaluation in ductal carcinoma in situ patients treated with breast-conserving therapy.
Huang NS; Si J; Yang BL; Quan CL; Chen JJ; Wu J
Cancer Med; 2018 Jan; 7(1):56-63. PubMed ID: 29271113
[TBL] [Abstract][Full Text] [Related]
14. Sentinel Node Procedure Obsolete in Lumpectomy for Ductal Carcinoma In Situ.
Heymans C; van Bastelaar J; Visschers RGJ; Vissers YLJ
Clin Breast Cancer; 2017 Jun; 17(3):e87-e93. PubMed ID: 28162949
[TBL] [Abstract][Full Text] [Related]
15. Sentinel lymph node biopsy is not necessary in patients diagnosed with ductal carcinoma in situ of the breast by stereotactic vacuum-assisted biopsy.
Kotani H; Yoshimura A; Adachi Y; Ishiguro J; Hisada T; Ichikawa M; Gondou N; Hattori M; Kondou N; Sawaki M; Fujita T; Iwata H
Breast Cancer; 2016 Mar; 23(2):190-4. PubMed ID: 24989112
[TBL] [Abstract][Full Text] [Related]
16. [A rare clinical manifestation of a combination tumor of cystosarcoma phylloides malignum and an intraductal cancer].
Schwickerath J; Blessing MH; Wolff F
Geburtshilfe Frauenheilkd; 1992 Sep; 52(9):557-9. PubMed ID: 1327943
[TBL] [Abstract][Full Text] [Related]
17. Metastatic "Ductal Carcinoma In Situ-Like" Lobular Carcinoma in a Lymph Node: A Case Report and Review of the Literature.
Tijani S; Sharma K; Yuen H; Shaaban A
Int J Surg Pathol; 2020 Jun; 28(4):436-439. PubMed ID: 31789065
[TBL] [Abstract][Full Text] [Related]
18. Extensive pure ductal carcinoma in situ of the breast: identification of predictors of associated infiltrating carcinoma and lymph node metastasis before immediate reconstructive surgery.
Guillot E; Vaysse C; Goetgeluck J; Falcou MC; Couturaud B; Fitoussi A; Fourchotte V; Laki F; Malhaire C; Sigal-Zafrani B; Sastre-Garau X; Bollet MA; Mosseri V; Reyal F
Breast; 2014 Apr; 23(2):97-103. PubMed ID: 24388733
[TBL] [Abstract][Full Text] [Related]
19. Does sentinel lymph node biopsy for screening high-grade ductal carcinoma in situ of the breast cause more harm than good?
Ramzi S; Najeeb E; Coulthard J; Jenkins S
Breast Cancer Res Treat; 2020 Jul; 182(1):47-54. PubMed ID: 32430678
[TBL] [Abstract][Full Text] [Related]
20. [Modern surgical treatment of breast cancer. 3rd Breast Cancer Consensus Conference].
Lázár G; Bursics A; Farsang Z; Harsányi L; Kósa C; Maráz R; Mátrai Z; Paszt A; Pavlovics G; Tamás R
Magy Seb; 2016 Sep; 69(3):117-32. PubMed ID: 27644928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]